New CAN-SPAM review increases risk for practices that email their patients

Why This Topic Matters

Practices that use email for marketing face increased scrutiny, and the article highlights why understanding the current federal requirements matters for reducing compliance risk and handling patient opt-outs appropriately.

Article Sections

1. Patient encounters

   Introduces the topic and frames the increased attention on patient-facing email marketing. It sets up the compliance concerns discussed in the rest of the article.

2. Intent, perception are the keys to CAN-SPAM

   Explains the general distinction between commercial and noncommercial email content and discusses how message purpose and presentation affect applicability. It also references the broader federal framework and related communication law context.

3. FTC ramps up email review

   Summarizes the FTC’s review of the rule and the potential impact on enforcement attention. It discusses why the review may matter to businesses that send email to patients.

4. How to offer email opt-out to patients

   Describes the article’s discussion of opt-out handling, notice format, timing, and general compliance considerations. It also covers operational issues that can affect receipt and tracking of opt-out requests.